How much they sold
About 12.0k
Operating income / revenue in 2025.
Simple version
Explain it like I’m ten
Numbers from the 2025 accounts. [R2025]
Did they make money?
-59.9k
Net result for 2025.
What’s left in the company
Equity -441.3k
Book equity at year-end.
Cash
2 103
Bank deposits and cash (when disclosed).
At a glance · 2025
Key figures
Revenue / sales
11 980
NOK · [R2025]
Net result
-59 897
NOK · [R2025]
Equity
-441 335
NOK · [R2025]
Cash
2 103
NOK · [R2025]
Total assets
2 103
NOK · [R2025]
Paid-in equity
494 430
NOK · [R2025]
Trends
3-year arc
Charts use figures extracted from published annual reports.
Sales / revenue
Equity & cash
Cost / investment lines
Salary costs (lønnskostnader)
FTEs (årsverk)
From notes when disclosed; blank years mean not found in OCR.
Analyst briefing
Company read — signals, board & numbers
Auto-written from filings, Brreg kunngjøringer, board timeline, address history, and the signal board. Interpretive — not investment advice.
Year by year
Comparing consecutive annual reports
Each filing pair has a dedicated, crawlable article page. Below is a preview of the latest comparison.
Executive summary
Auto-generated from filings
AEON BIOTECH AS · 3 published annual accounts (2023–2025). Latest year revenue 12.0k NOK, net result -59.9k NOK, equity -441.3k NOK, cash 2 103 NOK. Figures from Brønnøysund årsregnskapskopi / nøkkeltall. Interpretation
What improved
Vs prior year
- ↑
Net result
-207.2k → -59.9k NOK [R2025]
What deteriorated
Vs prior year
Buyer profile
What they may buy next
Sales-oriented read of industry, stage, filings, and registry signals — what this company is likely to purchase or hire over the next year. Interpretive, not a stated budget.
Health metrics
Ratios from the accounts
Source citations
Every material claim traces here
- [R2023] Årsregnskap 2023 · journal 2024 537527 · approved 20.06.2024 · registry 24.06.2024
- [R2024] Årsregnskap 2024 · journal 2025 439866 · approved 07.05.2025 · registry 17.05.2025
- [R2025] Årsregnskap 2025 · journal 2026 506340 · approved 25.05.2026 · registry 02.06.2026
Original annual reports
Source documents
Årsregnskap 2025
Approved 25.05.2026
Fee deadline 31.07.2026
Registry 02.06.2026
On time vs fee deadline
Årsregnskap 2024
Approved 07.05.2025
Fee deadline 31.07.2025
Registry 17.05.2025
On time vs fee deadline
Årsregnskap 2023
Approved 20.06.2024
Fee deadline 31.07.2024
Registry 24.06.2024
On time vs fee deadline
Signals
Hard · medium · soft
Derived from published accounts, Brreg roles, and kunngjøringer. Soft signals are interpretive — not facts or buying proof.
Registered address
Where the company sat over time
From Brreg «Endring av forretningsadresse» filings. Hubs and c/o addresses are tagged so you can see the path from incubator to own office.
Board & management
Who joined and left
Diffed from Styre / Daglig leder kunngjøringer (full public history).
Løsøreregisteret
Heftelser & rettsstiftelser
Active pant / utlegg and other registrations from Brreg’s public rettsstiftelser oppslag (not a full credit report).
Kunngjøringer
Full registry history
Ownership
Owners, officers & filing notes
Prefer Skatteetaten’s Aksjonærregisteret when available. Otherwise FirmaIQ shows Brreg officers (name + birth date) and any shareholder names disclosed in the annual-report «Aksjeeiere» note.